Routine Becomes Commonplace Although advancing technology remains an important aspect of instrument companies’ product development and reputation, companies are putting greater emphasis on instrumentation for so-called routine applications, such as quality analysis and quality control testing, or other nonresearch applications. Many of the fastest growing markets, including food and beverage and metals testing, do not […]
Atomic Spectroscopy Bruker AXS, following the acquisition of Quantron (see IBO 9/15/06), released “Brukerized” versions of Quantron’s arc-spark instruments around the first of the year. The Q6 Columbus is a laboratory system, as is the Q8 Magellan, which is priced at about $65,000. The Q8 Coronado (based on the Magellan) is an automated system for […]
The Indian government released its fiscal 2007–08 (starting April 1) budget on February 28. The budget contained favorable news for instrument companies and their customers. The annual budget for the Ministry of Science and Technology rose 46% to Rs3,271 ($74.0 million). Within the Ministry, the Department of Science and Technology received a 58% increase in […]
M&A activity among pharmaceutical outsourcing companies in 2006 was rapid. In this highly fragmented industry, consolidation often marked companies’ interest in establishing an international reach. Covalent Group’s acquisition of Remedium Oy is an example of this. Another trend was a shift among private equity firms towards expanding their portfolio outsourcing companies with an eye on […]
Washington, DC 2/9/07—Thermo Fisher Scientific has filed a petition of approval with the US Federal Trade Commission (FTC) to sell its centrifugal vacuum evaporators assets to Riverlake Partners and MVC Capital. Thermo Fisher Scientific is required to divest the business within five months as a condition of the FTC’s approval of the merger of Thermo […]
New York, NY 2/13/07; Carlsbad, CA 2/13/07—Invitrogen has agreed to sell BioReliance to private equity firm Avista Capital for $210 million. BioReliance, a contract service organization providing biological safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services, has annual revenues of $110 million and provides services to more than 600 clients per year. Tim […]
R&D activities in India have been booming: while the country only spent $2.9 billion on R&D in 2001, by 2004, this figure reached $24 billion. R&D spending is expected to reach $27.5 billion by 2010, and swell to $119 billion—2.7% of India’s estimated GDP—by 2020. There are currently 130 domestic firms and 220 multinational companies […]
Chelmsford, MA 2/5/07—Magellan Biosciences has sold Tek-Cel, a provider of laboratory sample management and storage solutions, to Hamilton, which sells laboratory robotics, chromatography and fluid subsystem products. Financial details were not disclosed. Hamilton is expected to keep TekCel’s headquarters in Hopkinton, Massachusetts and to grow Hamilton’s East Coast presence. Magellan President and CEO Dr. Robert […]
With 15 of the 23 Laboratory Instrument Sales Index companies reporting calendar year-end results, fourth quarter 2006 revenues grew an estimated 10.5% to $4,131 million. Fourth quarter operating profit growth rebounded from a year ago, improving 8.0% to $707 million. However, operating margin dropped 40 basis points to 17.1% of sales. The five largest instrument […]
While President Bush’s proposed budget for FY08 would increase the total federal R&D investment by 1.4% to $143.0 billion, federal support of basic and applied research would decline to $55.4 billion, a 2% drop from the FY07 budget. Not including NASA, the total budget increase for nondefense R&D agencies is only 0.8%, below the national […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
